Keystone eSymposia Logo

Maternal-Fetal Newborn Immunity

October 28-29, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Worldwide, deaths from adverse pregnancy outcomes of preterm birth (PTB) and stillbirth (SB) represent the longest, deadliest pandemic in human history. Neonatal infection (e.g. sepsis) is the main cause of death for children under 5 years; with premature babies being especially susceptible to infection. While the final common pathway for SB, PTB and neonatal sepsis is associated with aberrant inflammation in the maternal-fetal dyad, lack of insight into the underlying mechanisms has hampered identification of effective upstream preventative or downstream therapeutic interventions. A focus on immune regulation during pregnancy and in early life is thus urgently warranted. This interdisciplinary Keystone Conference on maternal-fetal-newborn immunity brings together the world’s experts across maternal, fetal and neonatal/infant immunity for the first time with the following goals:

  1. Identify the most important gaps in knowledge as well as experimental and analytical technology to answer the question: What is the problem? What is needed to tackle it?
  2. Craft the conceptual framework around the immunology of the maternal-fetal-newborn dyad to answer: How does the problem/s and possible solutions fit into the broader areas of immune -tolerance, -resilience, -resistance? How will the work proposed shift current paradigms?
  3. Initiate a global consortium to tackle adverse pregnancy outcomes on the necessary global scale. This is to answer: What does it take to recognize the maternal-fetal-newborn unit as one biological unit? What does it take to make this a global priority?

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSMaternal22




Program Details



Keynote Speaker


[Pedro L. Alonso, MD, PhD]

[Pedro L. Alonso, MD, PhD]
[World Health Organization, Director of the Global Malaria Programme]




Speaking at this eSymposia


Kjersti M. Aagaard

Baylor College of Medicine and Texas Children’s Hospital, USA


Galit Alter

MIT and Harvard University, USA


Petra Arck

University Medical Center Hamburg, Germany


Carolyn B. Coyne

Duke University, USA


Brice Gaudilliere

Stanford University School of Medicine, USA


Kevin C. Kain

University of Toronto, Canada


Sabra L. Klein

Johns Hopkins University, USA


Tobias R. Kollmann

Telethon Kids Institute, Australia


Joy Lawn

London School of Hygiene & Tropical Medicine, UK


Tippi MacKenzie

University of California, San Francisco, USA


Arnaud Marchant

Université libre de Bruxelles, Belgium


Mihai G. Netea

Radboud University, Netherlands


Ajoke Sobanjo-ter Meulen

Bill and Melinda Gates Foundation, USA


Tamara Tilburgs

Cincinnati Children's Hospital, USA


Valerie Verhasselt

University of Western Australia, Australia


Dorothee Viemann

Hannover Medical School, Germany


Sing Sing Way

Cincinnati Children's Hospital, USA


James L. Wynn

University of Florida, USA






Sponsors


 

sponsor-carousel-cellpress.png

 




Additional Support



 

sponsor-carousel-science-immunology.png

 

Funding for this conference was made possible [in part] by 1R13AI152254-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

sponsor-carousel-scientist.png

sponsor-carousel-stemcell-science-news.png





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia



Tags: